E. Smalley, First AAV gene therapy poised for landmark approval, Nat Biotechnol, vol.35, pp.998-1007, 2017.

F. M. Mowat, L. M. Occelli, and J. T. Bartoe, Gene therapy in a large animal model of PDE6A-retinitis pigmentosa, Front Neurosci, vol.11, 2017.

L. M. Occelli, C. Schön, and M. W. Seeliger, Gene supplementation rescues rod function and preserves photoreceptor and retinal morphology in dogs, leading the way toward treating human PDE6A-retinitis pigmentosa, Hum Gene Ther, vol.28, pp.1189-201, 2017.

V. Pichard, N. Provost, and A. Mendes-madeira, AAV-mediated gene therapy halts retinal degeneration in PDE6?-deficient dogs, Mol Ther, vol.24, pp.867-76, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01798999

K. L. Feathers, L. Jia, and N. D. Perera, Development of a gene-therapy vector for RDH12-associated retinal dystrophy, Hum Gene Ther, vol.30, 2019.

V. W. Choi, C. E. Bigelow, and T. L. Mcgee, AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice, Mol Ther Methods Clin Dev, vol.2, p.15022, 2015.

S. L. Boye, J. J. Peterson, and S. Choudhury, Gene therapy fully restores vision to the all-cone Nrl(-/-) Gucy2e(-/-) mouse model of Leber congenital amaurosis-1, Hum Gene Ther, vol.26, pp.575-92, 2015.

H. Zhong, A. Eblimit, and Y. Moayedi, AAV8(Y733F)-mediated gene therapy in a Spata7 knockout mouse model of Leber congenital amaurosis and retinitis pigmentosa, Gene Ther, vol.22, pp.619-646, 2015.

W. Zhang, L. Li, and Q. Su, Gene therapy using a miniCEP290 fragment delays photoreceptor degeneration in a mouse model of Leber congenital amaurosis, Hum Gene Ther, vol.29, pp.42-50, 2018.

S. Mookherjee, H. Y. Chen, and K. Isgrig, A CEP290 C-terminal domain complements the mutant CEP290 of Rd16 mice In trans and rescues retinal degeneration, Cell Rep, vol.25, pp.611-634, 2018.

A. Garanto, D. C. Chung, and L. Duijkers, In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery, Hum Mol Genet, vol.25, pp.2552-63, 2016.

N. G. Ghazi, E. B. Abboud, and S. R. Nowilaty, Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial, Hum Genet, vol.135, pp.327-370, 2016.

A. Chekuri, B. Sahu, and V. Chavali, Long-term effects of gene therapy in a novel mouse model of human MFRP-associated retinopathy, Hum Gene Ther, vol.30, pp.632-50, 2019.

A. Dinculescu, R. M. Stupay, and W. T. Deng, AAV-mediated clarin-1 expression in the mouse retina: implications for USH3A gene therapy, PLoS One, vol.11, p.148874, 2016.

M. D. Fischer, M. E. Mcclements, and C. Martinez-fernandez-de-la-camara, Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa, Mol Ther, vol.25, pp.1854-65, 2017.

Z. Wu, S. Hiriyanna, and H. Qian, A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration, Hum Mol Genet, vol.24, pp.3956-70, 2015.

J. C. Giacalone, J. L. Andorf, and Q. Zhang, Development of a molecularly stable gene therapy vector for the treatment of RPGR-associated X-linked retinitis pigmentosa, Hum Gene Ther, vol.30, 2019.

W. A. Beltran, A. V. Cideciyan, and S. E. Boye, Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations, Mol Ther, vol.25, pp.1866-80, 2017.

A. V. Cideciyan, R. Sudharsan, and V. L. Dufour, Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector, Proc Natl Acad Sci, vol.115, pp.8547-56, 2018.

S. Botta, E. Marrocco, and . Prisco-n-de, Rhodopsin targeted transcriptional silencing by DNA-binding, eLife, vol.5, p.12242, 2016.

S. Botta, . Prisco-n-de, and E. Marrocco, Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15, JCI Insight, vol.2, p.96560, 2017.

K. T. Mccullough, S. L. Boye, and D. Fajardo, Somatic gene editing of GUCY2D by AAV-CRISPR/Cas9 alters retinal structure and function in mouse and macaque, Hum Gene Ther, vol.30, pp.571-89, 2019.

S. Millington-ward, N. Chadderton, and M. O'reilly, Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa, Mol Ther, vol.19, pp.642-651, 2011.

G. W. Roddy, D. Yasumura, and M. T. Matthes, Long-term photoreceptor rescue in two rodent models of retinitis pigmentosa by adeno-associated virus delivery of Stanniocalcin-1, Exp Eye Res, vol.165, pp.175-81, 2017.

L. C. Byrne, D. Dalkara, and G. Luna, Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration, J Clin Invest, vol.125, pp.105-121, 2015.

, pigmentosa and discuss the technological, economic and ethical chal

, Michel Weber est consultant pour Novartis. Michel Weber et Guylène Le Meur sont actionnaires fondateurs de Horama

S. K. Verbakel and C. Huet-rac-van,-boon, Non-syndromic retinitis pigmentosa, Prog Retin Eye Res, vol.66, pp.157-86, 2018.

M. P. Simunovic, W. Shen, and J. Y. Lin, Optogenetic approaches to vision restoration, Exp Eye Res, vol.178, pp.15-26, 2019.

N. L. Jorstad, M. S. Wilken, and W. N. Grimes, Stimulation of functional neuronal regeneration from Müller glia in adult mice, Nature, vol.548, pp.103-110, 2017.

A. Rossi and A. Salvetti, Intégration des vecteurs AAV et mutagenèse insertionnelle, Med Sci (Paris), vol.32, pp.167-74, 2016.

I. P. Seitz, S. Michalakis, and B. Wilhelm, Superior retinal gene transfer and biodistribution profile of subretinal versus intravitreal delivery of AAV8 in nonhuman primates, Invest Ophthalmol Vis Sci, vol.58, pp.5792-801, 2017.

H. Khabou and D. Dalkara, La conception de vecteurs adaptés à la thérapie génique oculaire, Med Sci. (Paris), vol.31, pp.529-566, 2015.

M. Utz, V. Coussa, R. G. Antaki, and F. , Gene therapy for RPE65-related retinal disease, Ophthalmic Genet, vol.39, pp.671-678, 2018.

D. C. Chung and E. I. Traboulsi, Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions, J Am Assoc Pediatr Ophthalmol Strabismus, vol.13, pp.587-92, 2009.

G. M. Acland, G. D. Aguirre, and J. Bennett, Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness, Mol Ther, vol.12, pp.1072-82, 2005.

J. Bennicelli, J. F. Wright, and A. Komaromy, Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer, Mol Ther, vol.16, pp.458-65, 2008.

L. Meur, G. Stieger, K. Smith, and A. J. , Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium, Gene Ther, vol.14, pp.292-303, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02666207

S. G. Jacobson, G. M. Acland, and G. D. Aguirre, Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection, Mol Ther, vol.13, pp.1074-84, 2006.

S. G. Jacobson, A. V. Cideciyan, and R. Ratnakaram, Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years, Arch Ophthalmol, vol.130, pp.9-24, 2012.

L. Meur, G. Lebranchu, P. Billaud, and F. , Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis, Mol Ther, vol.26, pp.256-68, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01785885

J. Bennett, J. Wellman, and K. A. Marshall, Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial, Lancet, vol.388, pp.661-72, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02880968

J. Bainbridge, A. J. Smith, and S. S. Barker, Effect of gene therapy on visual function in Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2231-2240, 2008.

S. Russell, J. Bennett, and J. A. Wellman, Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet, vol.390, pp.849-60, 2017.

W. Xiong, D. M. Wu, and Y. Xue, AAV cis-regulatory sequences are correlated with ocular toxicity, Proc Natl Acad Sci, vol.116, pp.5785-94, 2019.

N. Provost, L. Meur, G. Weber, and M. , Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain, Mol Ther, vol.11, pp.275-83, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02681771

S. G. Jacobson, A. V. Cideciyan, and A. J. Roman, Improvement and decline in vision with gene therapy in childhood blindness, N Engl J Med, vol.372, pp.1920-1926, 2015.

J. Bainbridge, M. S. Mehat, and V. Sundaram, Long-term effect of gene therapy on Leber's congenital amaurosis, N Engl J Med, vol.372, pp.1887-97, 2015.

J. B. Ducloyer, L. Meur, G. Lebranchu, and P. , Macular fold complicating a subretinal injection of voretigene neparvovec, Ophthalmol Retina, 2019.

K. Ding, J. Shen, and Z. Hafiz, AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression, J Clin Invest, vol.130, 2019.

B. Cai, S. Sun, and Z. Li, Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases, Hum Genet, vol.137, pp.679-88, 2018.

B. Bakondi, W. Lv, and B. Lu, In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa, Mol Ther, vol.24, pp.556-63, 2016.

A. A. Castro, D. Lukovic, and P. Jendelova, Concise review: human induced pluripotent stem cell models of retinitis pigmentosa, Stem Cells, vol.36, pp.474-81, 2018.

M. Zimmermann, S. J. Lubinga, and R. Banken, Cost utility of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease, Value Health, vol.22, pp.161-168, 2019.

S. K. Cheong, J. M. Strazzeri, and D. R. Williams, All-optical recording and stimulation of retinal neurons in vivo in retinal degeneration mice, PLoS One, vol.13, p.194947, 2018.

H. Khabou, M. Garita-hernandez, and A. Chaffiol, Noninvasive gene delivery to foveal cones for vision restoration, JCI Insight, vol.3, p.96029, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01718061

A. Fischer, M. Dewatripant, and M. Goldman, L'innovation thérapeutique, à quel prix ?, Med Sci (Paris), vol.36, pp.389-93, 2020.

K. Yao, S. Qiu, and Y. V. Wang, Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas, Nature, vol.560, pp.484-492, 2018.

N. L. Jorstad, M. S. Wilken, and W. N. Grimes, Stimulation of functional neuronal regeneration from Müller glia in adult mice, Nature, vol.548, pp.103-110, 2017.

T. Cronin, L. H. Vandenberghe, and P. Hantz, Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter, EMBO Mol Med, vol.6, pp.1175-90, 2014.

A. Sengupta, A. Chaffiol, and E. Macé, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol Med, vol.8, pp.1248-64, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01375637